About us Pricing ContactSubscribe

R

Ross L. Levine

Memorial Sloan Kettering Cancer CenterORCID https://orcid.org/0000-0002-7884-1905

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Blood20165,802 citations

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Cancer Cell20052,972 citationsFirst authorCorresponding

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Blood20222,785 citations

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Cancer Cell20102,713 citations

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Cancer Cell20101,966 citations

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Blood20171,447 citations

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

PLoS Medicine20061,402 citationsCorresponding

Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation

Cancer Cell20111,293 citationsCorresponding

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

Cell stem cell2017829 citationsCorresponding

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment

Leukemia2007490 citations

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Leukemia2009418 citations

Ross L. Levine · Scinovex